Related Experiment Video

Updated: Jun 2, 2026

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
09:37

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

Published on: September 23, 2022

[Follow-up vaccination of children from 3 to 12 years]

Emmanuel Grimprel1

  • 1Hôpital Armand-Trousseau, AP-HP, université Paris-6, 75012 Paris. emmanuel.grimprel@trs.aphp.fr

La Revue Du Praticien
|May 10, 2011
PubMed

Insights

Regular childhood check-ups are key for updating immunizations, ensuring children receive vital vaccines like measles-mumps-rubella and hepatitis B, and identifying at-risk groups for additional protection.

Area of Science:

  • Pediatrics
  • Immunology
  • Public Health

Context:

  • Childhood vaccinations are critical for preventing infectious diseases.
  • Adolescent immunization schedules require regular review and updates.
  • Identifying at-risk populations ensures targeted vaccination strategies.

Purpose:

  • To outline recommended vaccination schedules for children aged 3-12.
  • To emphasize the importance of timely immunizations during pediatric consultations.
  • To highlight the need for supplementary vaccines in high-risk pediatric groups.

Summary:

  • Pediatric consultations between ages 3 and 12 should include a review and update of the child's immunization status.
  • Recommended vaccines include measles-mumps-rubella (MMR), meningococcal conjugate (MenACWY), and hepatitis B (HepB).
  • Hepatitis B vaccination follows a three-dose schedule until age 11, transitioning to a two-dose schedule between 11 and 15 years.
  • At-risk children may require additional vaccines, such as influenza, hepatitis A, and pneumococcal vaccines, based on age and risk factors.

Impact:

  • Ensures children maintain optimal protection against vaccine-preventable diseases.
  • Contributes to the reduction of infectious disease outbreaks in pediatric populations.
  • Promotes long-term public health by establishing robust childhood immunization programs.

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...